A blinded-initiation study of medication satisfaction in subjects with schizophrenia treated with paliperidone ER after suboptimal response to oral risperidone

Update Il y a 4 ans
Reference: EUCTR2007-004482-18

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective of this study is to assess the observed change in the Medication Satisfaction Questionnaire (MSQ) score, from baseline to the Week 6 endpoint, when paliperidone ER (6 mg to 12 mg) is administered for at least 4 weeks to subjects with schizophrenia who are suboptimally responsive to risperidone 4 mg to 6 mg.


Inclusion criteria

  • Schizophrenia

Links